Estimation of influenza vaccine effectiveness from routine surveillance data

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Kelly, Heath ^a   Carville, Kylie ^a   Grant, Kristina ^a   Jacoby, Peter ^b   Tran, Thomas ^a   Barr, Ian ^c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; HEALTH SURVEY; HUMAN; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; NOSE SMEAR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SENSITIVITY AND SPECIFICITY; THROAT CULTURE; VIRUS CULTURE; VIRUS STRAIN; ISOLATION AND PURIFICATION; ORTHOMYXOVIRUS; RETROSPECTIVE STUDY; STANDARD; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ORTHOMYXOVIRIDAE;

AUSTRALIA; CASE-CONTROL STUDIES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 63749103481     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005079     Document Type: Article

References (20)

1. Legrand J, Vergu E, Flahault A (2006) Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 24: 6605-6611.
2. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, et al. (2007) Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 25: 2842-2851.
3. Zangwill KM, Belshe RB (2004) Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 23: 189-197.
4. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V (2007) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev: CD001269.
5. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, et al. (1994) The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272: 1661-1665.
6. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, et al. (2005) Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366: 1165-1174.
7. Orenstein WA, Bernier RH, Hinman AR (1988) Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 10: 212-241.
8. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, et al. (2007) Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 36: 623-631.
9. Kelly H, Murphy A, Leong W, Leydon J, Tresise P, et al. (2000) Laboratory-supported influenza surveillance in Victorian sentinel general practices. Communicable Disease Intelligence 24: 379-383.
10. Thursky K, Cordova SP, Smith D, Kelly H (2003) Working towards a simple case definition for influenza surveillance. Journal of Clinical Virology 27: 170-179.
11. Druce JD, Tran T, Kelly H, Kaye M, Chibo D, et al. (2005) Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. Journal of Medical Virology 75: 122-129.
12. Watts CG, Andrews RM, Druce JD, Kelly HA (2003) Establishing thresholds for influenza surveillance in Victoria. Australian and New Zealand Journal of Public Health 27: 409-412.
13. StataCorp (2008) Statistical Software: Release 10.0. College Station, TX 77845 USA: Stata Corporation.
14. (1982) Concepts and procedures for laboratory-based influenza surveillance. Centers for Disease Control and Prevention and Pan-American Health Organization, Atlanta.
15. Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR (2008) The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Vaccine 26: 2142-2153.
16. Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, et al. (2008) Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics 26: 163-178.
17. Clothier H, Turner J, Hampson A, Kelly H (2006) Geographic representativeness for sentinel influenza surveillance: implications for routine surveillance and pandemic preparedness. Aust N Z J Public Health 30: 337-341.
18. Monto AS (2004) Occurrence of respiratory virus: time, place and person. Pediatr Infect Dis J 23: S58-64.
19. Monto AS, Koopman JS, Longini IM Jr (1985) Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 121: 811-822.
20. Wright PF, Thompson J, Karzon DT (1980) Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol 112: 814-819.